Longitudinal Comparative Analysis of Circulating Tumor DNA and Matched Tumor Tissue DNA in Patients with Metastatic Colorectal Cancer Receiving Palliative First-Line Systemic Anti-Cancer Therapy
Cancer Research and Treatment · 2024
DOI: 10.4143/crt.2024.016 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cancer Research and Treatment, 2024. Verfasst von Seung-Been Lee und 15 weiteren Autor:innen. Beteiligte Einrichtung: Macrogen, Inc., Seoul, Korea. Hauptthemen laut MEDLINE: Circulating Tumor DNA, Clonal Evolution, Colorectal Neoplasms, DNA Mutational Analysis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Ministry of Trade, Industry and Energy, Ministry of SMEs and Startups.
Abstract (Originalsprache)
Purpose
This study aimed to compare tumor tissue DNA (ttDNA) and circulating tumor DNA (ctDNA) to explore the clinical applicability of ctDNA and to better understand clonal evolution in patients with metastatic colorectal cancer undergoing palliative first-line systemic therapy.Materials and Methods We performed targeted sequencing analysis of 88 cancer-associated genes using germline DNA, ctDNA at baseline (baseline-ctDNA), and ctDNA at progressive disease (PD-ctDNA). The results were compared with ttDNA data.
Results
Among 208 consecutively enrolled patients, we selected 84 (41 males; median age, 59 years; range, 35 to 90 years) with all four sample types available. A total of 202 driver mutations were found in 34 genes. ttDNA exhibited the highest mutation frequency (n=232), followed by baseline-ctDNA (n=155) and PD-ctDNA (n=117). Sequencing ctDNA alongside ttDNA revealed additional mutations in 40 patients (47.6%). PD-ctDNA detected 13 novel mutations in 10 patients (11.9%) compared to ttDNA and baseline-ctDNA. Notably, seven mutations in five patients (6.0%) were missense or nonsense mutations in APC, TP53, SMAD4, and CDH1 genes. In baseline-ctDNA, higher maximal variant allele frequency (VAF) values (p=0.010) and higher VAF values of APC (p=0.012), TP53 (p=0.012), and KRAS (p=0.005) mutations were significantly associated with worse overall survival.
Conclusion
While ttDNA remains more sensitive than ctDNA, our ctDNA platform demonstrated validity and potential value when ttDNA was unavailable. Post-treatment analysis of PD-ctDNA unveiled new pathogenic mutations, signifying cancer’s clonal evolution. Additionally, baseline-ctDNA’s VAF values were prognostic after treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Macrogen, Inc., Seoul, Korea.
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
- Biomedical Research Institute, Seoul National University Bundang Hospital, Seongnam, Korea.
- Department of Statistics, Hankuk University of Foreign Studies, Yongin, Korea.
Förderung
- Ministry of Trade, Industry and Energy
- Ministry of SMEs and Startups
Zitieren
APA
Lee, S. B., Kim, J. W., Kim, H. G., Hwang, S. H., Kim, K. J., Lee, J. H., Seo, J., Kang, M., Jung, E. H., Suh, K. J., Kim, S. H., Kim, J. W., Kim, Y. J., Kim, J. H., Kwon, N. J., & Lee, K. W. (2024). Longitudinal Comparative Analysis of Circulating Tumor DNA and Matched Tumor Tissue DNA in Patients with Metastatic Colorectal Cancer Receiving Palliative First-Line Systemic Anti-Cancer Therapy. Cancer Research and Treatment. https://doi.org/10.4143/crt.2024.016
Vancouver
Lee SB, Kim JW, Kim HG, Hwang SH, Kim KJ, Lee JH, et al. Longitudinal Comparative Analysis of Circulating Tumor DNA and Matched Tumor Tissue DNA in Patients with Metastatic Colorectal Cancer Receiving Palliative First-Line Systemic Anti-Cancer Therapy. Cancer Research and Treatment. 2024. doi:10.4143/crt.2024.016
BibTeX
@article{Lee2024,
author = {Lee, Seung-Been and Kim, Ji-Won and Kim, Hong-Geun and Hwang, Sung-Hyun and Kim, Kui-Jin and Lee, Ju Hyun and Seo, Jeongmin and Kang, Minsu and Jung, Eun Hee and Suh, Koung Jin and Kim, Se Hyun and Kim, Jin Won and Kim, Yu Jung and Kim, Jee Hyun and Kwon, Nak-Jung and Lee, Keun-Wook},
title = {Longitudinal Comparative Analysis of Circulating Tumor DNA and Matched Tumor Tissue DNA in Patients with Metastatic Colorectal Cancer Receiving Palliative First-Line Systemic Anti-Cancer Therapy},
journal = {Cancer Research and Treatment},
year = {2024},
doi = {10.4143/crt.2024.016}
}
EUVIMED